GlassScriptPhysician profile
Michael A Campbell
NPI 1376523621
$3,557.24
in general payments reported to CMS, 2019-2025
35 companies · $703 in 2025
The $703 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,229 · 2020: $327 · 2022: $144 · 2023: $529 · 2024: $624 · 2025: $703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,856.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $925.06 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $485.45 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $310.62 | 2019-2025 | |
| Lilly USA, LLC | $235.26 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $191.51 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Sunovion Pharmaceuticals INC. | $160.56 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $150.01 | 2019-2025 | Gardasil 9, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.25 | 2019-2024 | Jardiance |
| Abbvie INC. | $95.81 | 2019-2025 | |
| Exact Sciences Corporation | $65.50 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Tolmar, INC. | $64.97 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.21 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $61.15 | 2019 | |
| Amarin Pharma, INC. | $57.32 | 2019-2020 | |
| Philips North America LLC | $53.55 | 2023-2024 | (Ak6) Vest Therapy |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $52.89 | 2025 | Sucraid |
| Supernus Pharmaceuticals, INC. | $37.07 | 2019 | |
| Phathom Pharmaceuticals, INC. | $36.23 | 2024-2025 | Voquezna |
| Scilex Pharmaceuticals INC. | $35.37 | 2019 | |
| Sanofi Pasteur INC. | $32.36 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.96 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $30.56 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.61 | 2019-2020 | |
| Shield Therapeutics INC | $24.66 | 2024 | |
| Antares Pharma, INC. | $23.97 | 2019 | |
| Glaxosmithkline, LLC. | $23.03 | 2024 | Shingrix, Arexvy |
| Hologic Sales and Service, LLC | $23.03 | 2025 | Aptima, Thinprep 2000 Processor |
| Medtronic Vascular, INC. | $20.85 | 2020 | |
| Valeritas, INC. | $18.56 | 2019 | |
| Mylan Specialty L.P. | $16.95 | 2019 | |
| Dexcom, INC. | $15.17 | 2025 | Dexcom G6 Transmitter |
| Avanir Pharmaceuticals, INC. | $14.73 | 2019 | |
| Lucid Diagnostics INC. | $13.56 | 2024 | |
| Avion Pharmaceuticals | $12.95 | 2019 | |
| Ermi LLC | $12.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.